Limits...
Prognosis of tumor infiltrating lymphocytes in operable tongue cancer patients

View Article: PubMed Central - HTML

No MeSH data available.


RRFS according to CD8/FOXP3 ratio.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4292410&req=5

Figure 2: RRFS according to CD8/FOXP3 ratio.

Mentions: Median follow up time was 31.4 months (range, 0.2-99.8 months). Higher number of CD4+ cells (p = 0.006), higher CD4/FOXP3 ratio (p = 0.012), lower CD3/CD4 ratio (p = 0.043), and higher CD4/CD8 ratio (p = 0.006) were correlated with the absence of lymphovascularinvasion (LVI). Patients with lower FOXP3+ TILs and higher CD8/FOXP3 ratio had marginally better RRFS (p = 0.071, and p = 0.069, respectively) (Figure 1 and Figure 2.). Patients with higher CD4/CD3 ratio had a significantly better DMFS (p = 0.036) (Figure 3).


Prognosis of tumor infiltrating lymphocytes in operable tongue cancer patients
RRFS according to CD8/FOXP3 ratio.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4292410&req=5

Figure 2: RRFS according to CD8/FOXP3 ratio.
Mentions: Median follow up time was 31.4 months (range, 0.2-99.8 months). Higher number of CD4+ cells (p = 0.006), higher CD4/FOXP3 ratio (p = 0.012), lower CD3/CD4 ratio (p = 0.043), and higher CD4/CD8 ratio (p = 0.006) were correlated with the absence of lymphovascularinvasion (LVI). Patients with lower FOXP3+ TILs and higher CD8/FOXP3 ratio had marginally better RRFS (p = 0.071, and p = 0.069, respectively) (Figure 1 and Figure 2.). Patients with higher CD4/CD3 ratio had a significantly better DMFS (p = 0.036) (Figure 3).

View Article: PubMed Central - HTML

No MeSH data available.